Investors React to Kimberly Clark’s $48.7B Kenvue Buyout

Tylenol product shelves and bottle representing Kimberly Clark’s $48.7B Kenvue acquisition and expansion into consumer health market

NEW YORK, BY TECHBISH NEWS In one of the biggest consumer-goods mergers in recent years, Kimberly Clark announced plans to acquire Kenvue, the maker of Tylenol and Listerine, in a $48.7 billion cash-and-stock deal. The move is set to reshape the personal-care and health-products landscape, sending Kimberly Clark stock tumbling while kenvue stock surged as … Read more